Pioneering adult stem cell trial approved by Japan
The first trial of stem cells produced from a patient's
own body has been approved by the Japanese government.
Stem cells can become any other part of the body - from
nerve to bone to skin - and are touted as the future of medicine. Researchers in Japan
will use the cells to attempt to treat a form of blindness - age-related
macular degeneration. The announcement was described as "a major step
forward" for research in the field.
There are already trials taking place using stem cells taken
from embryos. But this is ethically controversial and the cells will not match
a patient's own tissues, so there is a risk of rejection. Induced pluripotent stem cells, however, are made by coaxing
a sample of the patient's skin to become stem cells, so there should be no risk
of rejection.
Sight saving?
Prof Chris Mason, an expert on regenerative medicine at
University College London said: "This was expected, but it's obviously a
major step forward. "They are beneficial for two main reasons. One, they
are from the patients themselves so the chance of rejection is greatly reduced
and there are the ethical considerations - they do not have the baggage which
comes with embryonic stem cells.
"On the down side we are a decade behind on the
science. Induced pluripotent stem cells were discovered much later, so we're
behind on the safety." In 2012, Prof Shinya Yamanaka shared the Nobel prize for
medicine or physiology for his discovery that adult human tissue could be
coaxed back into a stem cell state.